These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
511 related articles for article (PubMed ID: 29436235)
21. The effect of vaginal erbium laser treatment on sexual function and vaginal health in women with a history of breast cancer and symptoms of the genitourinary syndrome of menopause: a prospective study. Arêas F; Valadares ALR; Conde DM; Costa-Paiva L Menopause; 2019 Sep; 26(9):1052-1058. PubMed ID: 31453969 [TBL] [Abstract][Full Text] [Related]
22. Safety and Efficacy of Erbium: Yttrium-Aluminum-Garnet Laser Treatment in Chinese Women with Mild-to-Moderate Stress Urinary Incontinence. Tan Y; Zhang Y; An J; Xu X; Deng J; Chen B; Pan W J Womens Health (Larchmt); 2024 May; 33(5):685-691. PubMed ID: 38563974 [No Abstract] [Full Text] [Related]
23. Efficacy of Two Laser Treatment Strategies for Breast Cancer Survivors With Genitourinary Syndrome of Menopause. Okui N; Okui M; Kouno Y; Nakano K; Gambacciani M Cureus; 2023 May; 15(5):e38604. PubMed ID: 37284382 [TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of intraurethral Erbium:YAG laser treatment in women with stress urinary incontinence following failed intravaginal laser therapy: a retrospective study. Tseng YL; Su CF Lasers Med Sci; 2023 Sep; 38(1):207. PubMed ID: 37688606 [TBL] [Abstract][Full Text] [Related]
25. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety. Vicariotto F; DE Seta F; Faoro V; Raichi M Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667 [TBL] [Abstract][Full Text] [Related]
26. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device. Vicariotto F; Raichi M Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062 [TBL] [Abstract][Full Text] [Related]
27. Comparison between erbium-doped yttrium aluminum garnet laser therapy and sling procedures in the treatment of stress and mixed urinary incontinence. Okui N World J Urol; 2019 May; 37(5):885-889. PubMed ID: 30116962 [TBL] [Abstract][Full Text] [Related]
28. First assessment of short-term efficacy of Er:YAG laser treatment on stress urinary incontinence in women: prospective cohort study. Fistonić N; Fistonić I; Lukanovič A; Findri Guštek Š; Sorta Bilajac Turina I; Franić D Climacteric; 2015; 18 Suppl 1():37-42. PubMed ID: 26366799 [TBL] [Abstract][Full Text] [Related]
29. Genitourinary syndrome of menopause (GSM) and laser VEL: a review. Elia D; Gambacciani M; Berreni N; Bohbot JM; Druckmann R; Geoffrion H; Haab F; Heiss N; Rygaloff N; Russo E Horm Mol Biol Clin Investig; 2019 Dec; 41(1):. PubMed ID: 31855563 [TBL] [Abstract][Full Text] [Related]
30. Lasers in the era of evidence-based medicine. Hillard TC Climacteric; 2020; 23(sup1):S6-S10. PubMed ID: 33124459 [TBL] [Abstract][Full Text] [Related]
31. Safety of vaginal erbium laser: A review of 113,000 patients treated in the past 8 years. Gambacciani M; Cervigni M; Gaspar A; Novakov Mikić A; Gaviria J; Koron N; Vizintin Z Climacteric; 2020; 23(sup1):S28-S32. PubMed ID: 33124457 [No Abstract] [Full Text] [Related]
32. Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause. Gaspar A; Brandi H; Gomez V; Luque D Lasers Surg Med; 2017 Feb; 49(2):160-168. PubMed ID: 27546524 [TBL] [Abstract][Full Text] [Related]
33. Efficacy and Safety of Combination Therapy With Vaginal and Urethral Erbium-Doped Yttrium-Aluminum-Garnet (Er:YAG) Laser for Overactive Bladder With Urinary Incontinence. Okui N; Okui MA Cureus; 2024 Jun; 16(6):e62363. PubMed ID: 39006699 [TBL] [Abstract][Full Text] [Related]
34. Erbium:YAG laser treatment of female stress urinary incontinence: midterm data. Kuszka A; Gamper M; Walser C; Kociszewski J; Viereck V Int Urogynecol J; 2020 Sep; 31(9):1859-1866. PubMed ID: 31828400 [TBL] [Abstract][Full Text] [Related]
35. "Two wavelengths endovaginal laser system": Clinical evaluation of a new device for mild SUI and vaginal atrophy treatment. Mezzana P Dermatol Ther; 2020 Nov; 33(6):e14445. PubMed ID: 33098352 [TBL] [Abstract][Full Text] [Related]
36. Long-term effect of thermoablative fractional CO González Isaza P; Jaguszewska K; Cardona JL; Lukaszuk M Int Urogynecol J; 2018 Feb; 29(2):211-215. PubMed ID: 28523400 [TBL] [Abstract][Full Text] [Related]
37. Histological findings after non-ablative Er:YAG laser therapy in women with severe vaginal atrophy. Gaspar A; Silva J; Calderon A; Di Placido V; Vizintin Z Climacteric; 2020; 23(sup1):S11-S13. PubMed ID: 33124455 [No Abstract] [Full Text] [Related]
38. European Board and College of Obstetrics and Gynaecology (EBCOG) position statement on the use of laser vaginal devices for treatment of genitourinary syndrome of menopause, vaginal laxity, pelvic organ prolapse and stress urinary incontinence. Giarenis I; Tsiapakidou S; Zacche M; Mukhopadhyay S; Mahmood T Eur J Obstet Gynecol Reprod Biol; 2024 Aug; 299():342-344. PubMed ID: 38811292 [TBL] [Abstract][Full Text] [Related]
39. Novel minimally invasive laser treatment of urinary incontinence in women. Ogrinc UB; Senčar S; Lenasi H Lasers Surg Med; 2015 Nov; 47(9):689-97. PubMed ID: 26388213 [TBL] [Abstract][Full Text] [Related]
40. Long-term clinical and histological safety and efficacy of the CO Casiraghi A; Calligaro A; Zerbinati N; Doglioli M; Ruffolo AF; Candiani M; Salvatore S Climacteric; 2023 Dec; 26(6):605-612. PubMed ID: 37650754 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]